HIND
Vyome Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.75
+1.74%Price chart
Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29
Key dataOct 29, 2026
Open$1.76
From 52W high−72.27%
Volume13135.00
Market cap$12.28M
P/E (TTM)—
P/S (TTM)94.7x
Div yield—
Key dataOct 29, 2026
Open
$1.76
From 52W high
−72.27%
Volume
13135.00
Market cap
$12.28M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.5x
P/E (TTM)
—
RSI (14)
29.3
MomentumView details →
1D Return
+1.74%
YTD Return
−50.29%
Similar companies
Latest newsMore news →
Vyome Holdings appointed Jerry Leonard as Chief Financial Officer, effective September 1, 2026, succeeding Robert Dickey, who resigned as Interim Chief Financial Officer effective August 31, 2026.63d agoVyome Holdings reported Q2 2026 revenue of $58,546, a net loss of $720,000, and a diluted loss per share of $0.10, with cash and cash equivalents of $7.9 million as of the period end.66d ago